1. Academic Validation
  2. Endogenous kynurenines as targets for drug discovery and development

Endogenous kynurenines as targets for drug discovery and development

  • Nat Rev Drug Discov. 2002 Aug;1(8):609-20. doi: 10.1038/nrd870.
Trevor W Stone 1 L Gail Darlington
Affiliations

Affiliation

  • 1 Institute of Biomedical and Life Sciences, West Medical Building, University of Glasgow, Glasgow G12 8QQ, UK. T.W.Stone@bio.gla.ac.uk
Abstract

The kynurenine pathway is the main pathway for tryptophan metabolism. It generates compounds that can modulate activity at glutamate receptors and possibly nicotinic receptors, in addition to some as-yet-unidentified sites. The pathway is in a unique position to regulate Other aspects of the metabolism of tryptophan to neuroactive compounds, and also seems to be a key factor in the communication between the nervous and immune systems. It also has potentially important roles in the regulation of cell proliferation and tissue function in the periphery. As a result, the pathway presents a multitude of potential sites for drug discovery in neuroscience, oncology and visceral pathology.

Figures